Free Trial
NASDAQ:NEOG

Neogen (NEOG) Stock Price, News & Analysis

Neogen logo
$8.64 -0.32 (-3.57%)
Closing price 04:00 PM Eastern
Extended Trading
$8.64 -0.01 (-0.06%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Neogen Stock (NASDAQ:NEOG)

Key Stats

Today's Range
$8.55
$9.09
50-Day Range
$8.43
$11.95
52-Week Range
$8.31
$18.58
Volume
2.45 million shs
Average Volume
3.28 million shs
Market Capitalization
$1.87 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.00
Consensus Rating
Moderate Buy

Company Overview

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Remove Ads

Neogen Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
70th Percentile Overall Score

NEOG MarketRank™: 

Neogen scored higher than 70% of companies evaluated by MarketBeat, and ranked 320th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Neogen has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Neogen has only been the subject of 1 research reports in the past 90 days.

  • Read more about Neogen's stock forecast and price target.
  • Earnings Growth

    Earnings for Neogen are expected to grow by 28.95% in the coming year, from $0.38 to $0.49 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Neogen is -3.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Neogen is -3.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Neogen has a P/B Ratio of 0.59. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Neogen's valuation and earnings.
  • Percentage of Shares Shorted

    10.72% of the float of Neogen has been sold short.
  • Short Interest Ratio / Days to Cover

    Neogen has a short interest ratio ("days to cover") of 7.3.
  • Change versus previous month

    Short interest in Neogen has recently decreased by 0.52%, indicating that investor sentiment is improving.
  • Dividend Yield

    Neogen does not currently pay a dividend.

  • Dividend Growth

    Neogen does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    10.72% of the float of Neogen has been sold short.
  • Short Interest Ratio / Days to Cover

    Neogen has a short interest ratio ("days to cover") of 7.3.
  • Change versus previous month

    Short interest in Neogen has recently decreased by 0.52%, indicating that investor sentiment is improving.
  • News Sentiment

    Neogen has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Neogen this week, compared to 6 articles on an average week.
  • Search Interest

    2 people have searched for NEOG on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Neogen to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Neogen insiders have bought more of their company's stock than they have sold. Specifically, they have bought $418,504.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 1.13% of the stock of Neogen is held by insiders.

  • Percentage Held by Institutions

    96.73% of the stock of Neogen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Neogen's insider trading history.
Receive NEOG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neogen and its competitors with MarketBeat's FREE daily newsletter.

NEOG Stock News Headlines

Neogen Becomes Oversold (NEOG)
Trump’s Treasure Map [Pic inside]
We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public.
See More Headlines

NEOG Stock Analysis - Frequently Asked Questions

Neogen's stock was trading at $12.14 at the beginning of the year. Since then, NEOG shares have decreased by 29.0% and is now trading at $8.6150.
View the best growth stocks for 2025 here
.

Neogen Co. (NASDAQ:NEOG) posted its earnings results on Friday, January, 10th. The company reported $0.11 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.01) by $0.12. The firm's revenue was up .7% compared to the same quarter last year.

Shares of Neogen split on Tuesday, January 2nd 2018. The 4-3 split was announced on Friday, December 8th 2017. The newly issued shares were payable to shareholders after the closing bell on Friday, December 29th 2017. An investor that had 100 shares of stock prior to the split would have 133 shares after the split.

Top institutional shareholders of Neogen include Vanguard Group Inc. (9.97%), Norges Bank (8.06%), William Blair Investment Management LLC (6.61%) and Baillie Gifford & Co. (4.49%). Insiders that own company stock include John Edward Adent, David H Naemura, Douglas Edward Jones, Steven J Quinlan, Jason Warren Lilly, William T Boehm, James P Tobin, James C Borel, Ronald D Green and Darci L Vetter.
View institutional ownership trends
.

Shares of NEOG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Neogen investors own include NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Netflix (NFLX) and Visa (V).

Company Calendar

Last Earnings
1/10/2025
Today
3/28/2025
Next Earnings (Estimated)
4/09/2025
Fiscal Year End
5/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostic substances
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:NEOG
Employees
2,110
Year Founded
1982

Price Target and Rating

Average Stock Price Target
$14.00
High Stock Price Target
$15.00
Low Stock Price Target
$13.00
Potential Upside/Downside
+62.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
22.62
P/E Growth
N/A
Net Income
$-9,420,000.00
Pretax Margin
-55.20%

Debt

Sales & Book Value

Annual Sales
$913.83 million
Cash Flow
$0.88 per share
Price / Cash Flow
9.80
Book Value
$14.52 per share
Price / Book
0.59

Miscellaneous

Free Float
214,493,000
Market Cap
$1.86 billion
Optionable
Optionable
Beta
1.27

Social Links

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report

This page (NASDAQ:NEOG) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners